Work

Cirrhosis Caused by Nilotinib in Dose-Dependent Hepatotoxicity: Role of Gamma-Glutamyl Transferase in Management

Year: 2025

Type: article

Abstract: We report nilotinib hepatotoxicity in a patient with chronic myeloid leukemia (CML) who presented with isolated elevations of gamma-glutamyl transferase (GGT). Cirrhosis was confirmed by clinical, radiologic, and histologic findings. Therapy for CML was continued, guided by monitoring BCR-ABL1 levels and declining GGT levels. Cirrhosis regression was evaluated using liver stiffness measurements and histology. Isolated GGT elevations in diagnosis and improvement in hepatotoxicity with dose reduction have not been previously reported. Treatment continuation while monitoring GGT and BCR-ABL1 levels resulted in disease remission and regression of cirrhosis. Our report will be useful to clinicians managing patients treated with nilotinib.

Source: Annals of Internal Medicine Clinical Cases

DOI: 10.7326/aimcc.2024.0294

Authors: Jacob Korula, Edward Reece, Merrill Shum, Sanja Krajisnik, Carlos Echeverria, Paul O'Connor, Conrad Lu

Institutions: Good Samaritan Hospital, PIH Health, Kaiser Permanente Riverside Medical Center, University of California, Los Angeles

Language: English

Topic: Drug-Induced Hepatotoxicity and Protection

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4406120560

FWCI:

Cites: 11

Cited by:

Related to: 10